Pharmaceutical compositions for rectal administration

A technology of rectal administration and composition, applied in the field of pharmaceutical composition for rectal administration, capable of solving problems such as rectal foam preparations or compositions for undisclosed infections

Inactive Publication Date: 2015-12-09
CIPLA LTD
View PDF13 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the prior art does not disclose rectal foam formulations or compositions specifically for the treatment of infections caused by Clostridium difficile

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical compositions for rectal administration

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0123] method:

[0124] (1) Heat the propylene glycol and dissolve the emulsifying wax.

[0125] (2) Sodium metabisulfite and disodium edetate are dispersed in the solution obtained in step (1).

[0126] (3) Fidaxomicin is dispersed in the solution obtained in step (2) to form a uniform suspension.

[0127] (4) The suspension obtained in step (3) is filled in a container and charged with a propellant.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
Login to view more

Abstract

The present invention relates to pharmaceutical compositions for rectal administration comprising fidaxomicin and to a process for preparing the pharmaceutical compositions for rectal administration. The invention also relates to an aerosol canister comprising a foamable pharmaceutical composition comprising fidaxomicin for rectal administration and to the treatment or maintenance of remission of infections such as diarrhoea caused by Clostridium difficile..

Description

field of invention [0001] The present invention relates to pharmaceutical compositions for rectal administration comprising fidaxomicin, processes for preparing the pharmaceutical compositions for rectal administration and their use in the treatment of infections caused by Clostridium difficile use. Background of the invention [0002] Clostridium difficile is a Gram-positive toxigenic bacterium. The bacterium invades the intestines of patients whose normal gut flora has been suppressed by treatment with broad-spectrum antibiotics. The bacterial toxin causes varying degrees of damage to the epithelium of the large intestine (ie, the colon) and causes a range of diseases ranging from mild diarrhea to severe colitis. As antibiotic treatment induces the onset of C. difficile disease, the associated syndrome is known as antibiotic-associated diarrhea and colitis. This is becoming a growing problem, with highly virulent strains emerging and older populations most susceptible t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/12A61K31/00
CPCA61K9/0031A61K9/122A61K31/351A61K45/06A61K31/7048A61P31/04A61K2300/00A61K9/124A61M31/00C07H17/08
Inventor S·M·普伦戴尔G·马尔霍特拉
Owner CIPLA LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products